Monkey study points to HIV vulnerability for vaccine attack

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people.

Related Keywords

, National Institute Of Allergy , Vaccine Research Center , National Institutes Of Health , Nih National Institute Of Allergy , National Institute , Science Translational Medicine , Infectious Diseases , National Institutes , Antibodies , Shiv , Allergy , Ntibody , Flood , Fell , Cell Culture , Electron , Hiv 1 , Medical Research , Medicine , Embrane , Micrograph , Placebo , Protein , Research , Vaccine , Virus ,